Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07120776) titled 'Positron Emission Tomography to Assess the Effect of Camzyos on Ischaemia in HOCM: PEACH Trial' on Aug. 1.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: University of Manchester
Condition:
Hypertrophic Obstructive Cardiomyopathy (HOCM)
Left Ventricular Outflow Tract Obstruction
Myocardial Ischaemia
Intervention:
Drug: Camzyos (Mavacamten)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 2025
Target Sample Size: 75
Countries of Recruitment:
Un...